Mitrazol™ Powder

Powder used for the treatment of superficial skin infections caused by yeast.

Offer available for: licensing

Pharmaceutical form and dosage: Powder

Type:

- Devices
- FP (finished products)
- OTC (over the counter drugs)

Therapeutic target:

- Infectious Diseases

Full Description:
Mitrazol™ Powder provides the strength of 2% miconazole nitrate in a non-caking, cornstarch base.

Mitrazol™ Powder is a treatment for a variety of superficial fungal infections including yeast (Candida albicans), as well as a cure for athlete’s foot, ringworm, and jock itch.

The product has been fully tested for Dermal Irritation, Occular Irritation, Preservative Efficacy, and published In Vitro Inhibition Study.

Mitrazol powder is biodegradable and won't cause granulomas which can occur with talc-based powders.

Availability and Market information:

Status:

Market(s) and Registration Info: (date: concerns Marketing Authorization)
- United States of America

Market information
First on the market in: United States of America

Other Market Info: Available for licensing and distribution outside the United States, Canada, and Mexico.

  Contact for this offer: Jay Nisbet